Alcresta Therapeutics Revenue, Growth & Competitor Profile

DBA ALCRESTA, INC.

Company Profile & Annual Report for Alcresta Therapeutics

Access the complete profile.

Alcresta Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	339112 Surgical & Medical Instrument Manufacturing
Address	130 Turner St Bldg 3 Ste 200 Waltham, MA 02453

Note: Revenues for privately held companies are statistical evaluations.


Alcresta Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Alcresta Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Alcresta Therapeutics is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Alcresta Therapeutics Annual Revenue and Growth Rate

Alcresta Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Alcresta Therapeutics's revenues are gauged from an analysis of company filings.

Alcresta Therapeutics's Income Statement (based on Industry Averages)

Alcresta Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Alcresta Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
March 3, 2020	17	50%	$20 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Alcresta Therapeutics is developing and marketing. Alcresta Therapeutics doesn't have any recent trademark applications, indicating Alcresta Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ALCRESTA PHARMACEUTICALS Medical nutritional formula, namely, formula for use as a nutritional supplement; infant formula; dietetic foods adapted for medical use; enzymes for medical purposes; dietary and nutritional supplements; pharmaceutical preparations for the treatment of nutritional, gastrointestinal, digestive, metabolic, urological, nephrology, endocrine, oncologic, rheumatologic, inflammatory, pediatric, elderly, immunologic, cardiovascular, dermatologic, hematologic, infectious, circulatory, surgery and would healing, mental illness, pulmonary, muscular and respiratory diseases and disorders	07/20/2015
FULFILLING POTENTIAL Medical nutritional formula, namely, formula for use as a nutritional supplement; infant formula; dietetic foods adapted for medical use; enzymes for medical purposes; dietary and nutritional supplements; pharmaceutical preparations for the treatment of nutritional, gastrointestinal, digestive, metabolic, urological, nephrology, endocrine, oncologic, rheumatologic, inflammatory, pediatric, elderly, immunologic, cardiovascular, dermatologic, hematologic, infectious, circulatory, surgery and would healing, mental illness, pulmonary, muscular and respiratory diseases and disorders	07/20/2015

See all trademarks and details in the Full Report.

Market Share of Alcresta Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Alcresta Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Alcresta Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
REPLIGEN	Waltham, Massachusetts,united States, MA	100
APELLIS PHARMACEUTICALS	Waltham, MA	67
CUBIST PHARMACEUTICALS	Lexington, MA	59
BIOVERATIV U.S. LLC.	Waltham, MA	58
ABCAM	Waltham, MA	29
KARYOPHARM THERAPEUTICS	Newton, MA	25

Future Competition: Alcresta Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Alcresta Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)